Board Change • May 11
High number of new directors Independent Director Ellen Sun was the last director to join the board, commencing their role in 2026. Declared Dividend • May 01
First quarter dividend of US$0.10 announced Shareholders will receive a dividend of US$0.10. Ex-date: 12th May 2026 Payment date: 22nd May 2026 Dividend yield will be 19%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 10 years. However, payments have been volatile during that time. Announcement • Apr 22
Natural Health Trends Corp. to Report Q1, 2026 Results on Apr 29, 2026 Natural Health Trends Corp. announced that they will report Q1, 2026 results at 9:00 AM, US Eastern Standard Time on Apr 29, 2026 Announcement • Mar 25
Natural Health Trends Corp., Annual General Meeting, May 07, 2026 Natural Health Trends Corp., Annual General Meeting, May 07, 2026, at 10:00 China Standard Time. Location: units 1205-07, 12f, mira place tower a, 132 nathan road, tsimshatsui, kowloon, hong kong Hong Kong Declared Dividend • Feb 06
Fourth quarter dividend reduced to US$0.10 Dividend of US$0.10 is 50% lower than last year. Ex-date: 17th February 2026 Payment date: 27th February 2026 Dividend yield will be 18%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. Reported Earnings • Feb 05
Full year 2025 earnings released: US$0.077 loss per share (vs US$0.05 profit in FY 2024) Full year 2025 results: US$0.077 loss per share (down from US$0.05 profit in FY 2024). Revenue: US$39.8m (down 7.4% from FY 2024). Net loss: US$882.0k (down 254% from profit in FY 2024). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Buy Or Sell Opportunity • Feb 05
Now 26% overvalued after recent price rise Over the last 90 days, the stock has risen 59% to US$4.00. The fair value is estimated to be US$3.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.3% over the last 3 years. Meanwhile, the company became loss making. Announcement • Feb 04
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on February 27, 2026 On February 2, 2026, the Board of Directors of Natural Health Trends Corp. declared a quarterly cash dividend of $0.10 on each share of common stock outstanding. The dividend will be payable on February 27, 2026 to stockholders of record as of February 17, 2026. Announcement • Jan 28
Natural Health Trends Corp. to Report Q4, 2025 Results on Feb 04, 2026 Natural Health Trends Corp. announced that they will report Q4, 2025 results at 9:00 AM, US Eastern Standard Time on Feb 04, 2026 Buy Or Sell Opportunity • Jan 13
Now 22% overvalued Over the last 90 days, the stock has fallen 20% to US$3.53. The fair value is estimated to be US$2.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.3% over the last 3 years. Meanwhile, the company became loss making. New Risk • Dec 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 1.9% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$35.4m market cap). Declared Dividend • Nov 09
Third quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 18th November 2025 Payment date: 28th November 2025 Dividend yield will be 24%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 10 years. However, payments have been volatile during that time. Reported Earnings • Nov 06
Third quarter 2025 earnings released: US$0.037 loss per share (vs US$0.003 profit in 3Q 2024) Third quarter 2025 results: US$0.037 loss per share (down from US$0.003 profit in 3Q 2024). Revenue: US$9.48m (down 11% from 3Q 2024). Net loss: US$431.0k (down US$466.0k from profit in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings. Announcement • Nov 05
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on November 28, 2025 On November 3, 2025, Natural Health Trends Corp.'s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 28, 2025 to stockholders of record as of November 18, 2025. Announcement • Oct 30
Natural Health Trends Corp. to Report Q3, 2025 Results on Nov 05, 2025 Natural Health Trends Corp. announced that they will report Q3, 2025 results at 9:00 AM, US Eastern Standard Time on Nov 05, 2025 Declared Dividend • Aug 03
Second quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 12th August 2025 Payment date: 22nd August 2025 Dividend yield will be 17%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 26x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 2,833% to bring the payout ratio under control, which is more than the 28% EPS growth achieved over the last 5 years. New Risk • Jul 31
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.8% Last year net profit margin: 2.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 13x earnings per share. Paying a dividend despite having no free cash flows. Minor Risks Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (US$53.1m market cap). Reported Earnings • Jul 31
Second quarter 2025 earnings released: EPS: US$0.001 (vs US$0.015 in 2Q 2024) Second quarter 2025 results: EPS: US$0.001 (down from US$0.015 in 2Q 2024). Revenue: US$9.81m (down 6.3% from 2Q 2024). Net income: US$15.0k (down 91% from 2Q 2024). Profit margin: 0.2% (down from 1.7% in 2Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Jul 30
Natural Health Trends Corp. Declares A Quarterly Cash Dividend on Common Stock , Payable on August 22, 2025 On July 28, 2025, Natural Health Trends Corp. Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on August 22, 2025 to stockholders of record as of August 12, 2025. Announcement • Jul 23
Natural Health Trends Corp. to Report Q2, 2025 Results on Jul 30, 2025 Natural Health Trends Corp. announced that they will report Q2, 2025 results at 9:00 AM, US Eastern Standard Time on Jul 30, 2025 Announcement • May 22
OptiBiotix Health plc Announces Launch of SlimBiome Products with NASDAQ Listed Partner, Natural Health Trends Corp OptiBiotix Health plc announced the launch of products containing SlimBiome® with a NASDAQ listed partner, Natural Health Trends Corp. NHT is an international direct selling and ecommerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality products under the NHT global brand. The product, which was produced and shipped in final product format by OptiBiotix is a Tomato Soup formulation, TwinSlim Tomato Soup, developed specifically for NHT and its global markets. The product has been launched in Hong Kong for the Chinese market with the product shipped for launch in the USA in the upcoming weeks. OptiBiotix has been involved in presentations to NHT's Asian distributors and filming videos explaining the science and benefits of SlimBiome® for both the Asian and USA markets. This is the second USA partner launching SlimBiome®? products in the last few months, with a third, one of the USA's leading weight management brands, expected to launch in the near future. This is all part of the Company's strategy to develop and market clinically proven and patented products with functional benefits (for SlimBiome®?: reduce hunger and food cravings) and grow business in the high growth markets of Asia, particularly India, and the large USA market, through a mix of ingredient and finished products sold by brand owners, specialised distributors and e-commerce channels. OptiBiotix is now beginning to see returns from the investments made in clinical studies, intellectual property, and more recently supporting partners in their marketing at a time when the anti-obesity drugs have enhanced consumer awareness of the benefits of appetite suppression in weight management. The focus now is on increasing the number of large partners and delivering regular repeat orders to reach group profitability. Declared Dividend • May 02
First quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 13th May 2025 Payment date: 23rd May 2025 Dividend yield will be 16%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 18x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,916% to bring the payout ratio under control, which is more than the 44% EPS growth achieved over the last 5 years. Announcement • Apr 30
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on May 23, 2025 On April 28, 2025, Natural Health Trends Corp. Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on May 23, 2025 to stockholders of record as of May 13, 2025. Announcement • Apr 23
Natural Health Trends Corp. to Report Q1, 2025 Results on Apr 30, 2025 Natural Health Trends Corp. announced that they will report Q1, 2025 results at 9:00 AM, US Eastern Standard Time on Apr 30, 2025 Announcement • Mar 26
Natural Health Trends Corp., Annual General Meeting, May 06, 2025 Natural Health Trends Corp., Annual General Meeting, May 06, 2025. Location: at the company`s office located, at 19745 colima rd., suite 8, rowland heights, ca 91748 United States Declared Dividend • Feb 09
Fourth quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 18th February 2025 Payment date: 28th February 2025 Dividend yield will be 15%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 16x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,682% to bring the payout ratio under control, which is more than the 55% EPS growth achieved over the last 5 years. Reported Earnings • Feb 06
Full year 2024 earnings released: EPS: US$0.05 (vs US$0.05 in FY 2023) Full year 2024 results: EPS: US$0.05 (in line with FY 2023). Revenue: US$43.0m (down 2.2% from FY 2023). Net income: US$572.0k (flat on FY 2023). Profit margin: 1.3% (in line with FY 2023). Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 12% per year. Announcement • Feb 06
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on February 28, 2025 Natural Health Trends Corp. announced that Board of Directors declared a quarterly cash dividend of $0.20 per share, which will be payable on February 28, 2025 to stockholders of record as of February 18, 2025. Announcement • Jan 29
Natural Health Trends Corp. to Report Q4, 2024 Results on Feb 05, 2025 Natural Health Trends Corp. announced that they will report Q4, 2024 results at 9:00 AM, Eastern Standard Time on Feb 05, 2025 Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to US$4.14, the stock trades at a trailing P/E ratio of 63x. Average trailing P/E is 29x in the Personal Products industry in the US. Total loss to shareholders of 8.3% over the past three years. Declared Dividend • Nov 01
Third quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 12th November 2024 Payment date: 22nd November 2024 Dividend yield will be 13%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 12x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,251% to bring the payout ratio under control. However, EPS has declined by 24% over the last 5 years so the company would need to reverse this trend. Reported Earnings • Nov 01
Third quarter 2024 earnings released: EPS: US$0.003 (vs US$0.015 in 3Q 2023) Third quarter 2024 results: EPS: US$0.003 (down from US$0.015 in 3Q 2023). Revenue: US$10.7m (flat on 3Q 2023). Net income: US$35.0k (down 80% from 3Q 2023). Profit margin: 0.3% (down from 1.6% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Announcement • Oct 23
Natural Health Trends Corp. to Report Q3, 2024 Results on Oct 30, 2024 Natural Health Trends Corp. announced that they will report Q3, 2024 results at 9:00 AM, US Eastern Standard Time on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to US$5.60, the stock trades at a trailing P/E ratio of 72.1x. Average trailing P/E is 25x in the Personal Products industry in the US. Total returns to shareholders of 14% over the past three years. Declared Dividend • Aug 02
Second quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 13th August 2024 Payment date: 23rd August 2024 Dividend yield will be 11%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 10x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,042% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend. Reported Earnings • Aug 01
Second quarter 2024 earnings released: EPS: US$0.015 (vs US$0.019 loss in 2Q 2023) Second quarter 2024 results: EPS: US$0.015 (up from US$0.019 loss in 2Q 2023). Revenue: US$10.5m (flat on 2Q 2023). Net income: US$173.0k (up US$392.0k from 2Q 2023). Profit margin: 1.7% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • Jul 24
Natural Health Trends Corp. to Report Q2, 2024 Results on Jul 31, 2024 Natural Health Trends Corp. announced that they will report Q2, 2024 results at 9:00 AM, US Eastern Standard Time on Jul 31, 2024 Announcement • Jul 03
Natural Health Trends Corp.(NasdaqCM:NHTC) dropped from Russell 3000E Value Index Natural Health Trends Corp.(NasdaqCM:NHTC) dropped from Russell 3000E Value Index Declared Dividend • May 05
First quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 13th May 2024 Payment date: 24th May 2024 Dividend yield will be 12%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 18x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,939% to bring the payout ratio under control. However, EPS has declined by 52% over the last 5 years so the company would need to reverse this trend. Announcement • May 03
Natural Health Trends Corp. Declares Quarterly Cash Dividend , Payable on May 24, 2024 Natural Health Trends Corp. announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on May 24, 2024 to stockholders of record as of May 14, 2024. Reported Earnings • May 02
First quarter 2024 earnings released: EPS: US$0.016 (vs US$0.022 in 1Q 2023) First quarter 2024 results: EPS: US$0.016 (down from US$0.022 in 1Q 2023). Revenue: US$11.0m (down 7.7% from 1Q 2023). Net income: US$188.0k (down 27% from 1Q 2023). Profit margin: 1.7% (down from 2.2% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Announcement • Apr 26
Natural Health Trends Corp. to Report Q1, 2024 Results on May 01, 2024 Natural Health Trends Corp. announced that they will report Q1, 2024 results at 9:00 AM, US Eastern Standard Time on May 01, 2024 Announcement • Apr 02
Natural Health Trends Corp., Annual General Meeting, May 14, 2024 Natural Health Trends Corp., Annual General Meeting, May 14, 2024, at 09:00 Pacific Daylight. Location: 19745 Colima Rd., Suite 8, Rowland Heights, California United States Agenda: To discuss election of four directors to the Board of Directors of the company to serve until the next annual meeting of the company's stockholders; to discuss advisory vote on compensation of the company's named executive officers; to discuss and ratify of the appointment of Marcum LLP as independent registered public accounting firm for the company for the year ending December 31, 2024; to discuss and approve and adoption of the amendment to the company's certificate of incorporation to provide for the exculpation of certain of company officers, as permitted by recent amendments to the Delaware General Corporation Law; and to consider other matters. Declared Dividend • Feb 10
Fourth quarter dividend of US$0.20 announced Dividend of US$0.20 is the same as last year. Ex-date: 16th February 2024 Payment date: 1st March 2024 Dividend yield will be 13%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 22x earnings) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 2,453% to bring the payout ratio under control. However, EPS has declined by 55% over the last 5 years so the company would need to reverse this trend. Reported Earnings • Feb 08
Full year 2023 earnings released: EPS: US$0.05 (vs US$0.028 in FY 2022) Full year 2023 results: EPS: US$0.05 (up from US$0.028 in FY 2022). Revenue: US$43.9m (down 11% from FY 2022). Net income: US$568.0k (up 82% from FY 2022). Profit margin: 1.3% (up from 0.6% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Announcement • Feb 07
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on March 1, 2024 On February 5, 2024, Natural Health Trends Corp.’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on March 1, 2024 to stockholders of record as of February 20, 2024. Announcement • Feb 01
Natural Health Trends Corp. to Report Q4, 2023 Results on Feb 07, 2024 Natural Health Trends Corp. announced that they will report Q4, 2023 results at 9:00 AM, US Eastern Standard Time on Feb 07, 2024 Upcoming Dividend • Nov 06
Upcoming dividend of US$0.20 per share at 14% yield Eligible shareholders must have bought the stock before 13 November 2023. Payment date: 24 November 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 14%. Within top quartile of American dividend payers (5.1%). Higher than average of industry peers (3.2%). Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: US$15.04 (vs US$0.004 in 3Q 2022) Third quarter 2023 results: EPS: US$15.04 (up from US$0.004 in 3Q 2022). Revenue: US$10.6m (down 9.4% from 3Q 2022). Net income: US$172.0k (up 266% from 3Q 2022). Profit margin: 1.6% (up from 0.4% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Announcement • Nov 02
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on November 24, 2023 On October 30, 2023, Natural Health Trends Corp.’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 24, 2023 to stockholders of record as of November 14, 2023. Announcement • Oct 26
Natural Health Trends Corp. to Report Q3, 2023 Results on Nov 01, 2023 Natural Health Trends Corp. announced that they will report Q3, 2023 results at 9:00 AM, US Eastern Standard Time on Nov 01, 2023 Upcoming Dividend • Aug 07
Upcoming dividend of US$0.20 per share at 14% yield Eligible shareholders must have bought the stock before 14 August 2023. Payment date: 25 August 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 14%. Within top quartile of American dividend payers (4.7%). Higher than average of industry peers (2.4%). Announcement • Aug 03
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on August 25, 2023 Natural Health Trends Corp. announced that on July 31, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on August 25, 2023 to stockholders of record as of August 15, 2023. New Risk • Aug 03
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.6% Last year net profit margin: 1.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 33x earnings per share. Paying a dividend despite having no free cash flows. Earnings have declined by 64% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (0.6% net profit margin). Market cap is less than US$100m (US$65.9m market cap). Reported Earnings • Aug 03
Second quarter 2023 earnings released: US$0.019 loss per share (vs US$0.016 profit in 2Q 2022) Second quarter 2023 results: US$0.019 loss per share (down from US$0.016 profit in 2Q 2022). Revenue: US$10.5m (down 21% from 2Q 2022). Net loss: US$219.0k (down 220% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • Jul 28
Natural Health Trends Corp. to Report Q2, 2023 Results on Aug 02, 2023 Natural Health Trends Corp. announced that they will report Q2, 2023 results at 9:00 AM, US Eastern Standard Time on Aug 02, 2023 Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Nelson Wong was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • May 08
Upcoming dividend of US$0.20 per share at 14% yield Eligible shareholders must have bought the stock before 15 May 2023. Payment date: 26 May 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 14%. Within top quartile of American dividend payers (5.1%). Higher than average of industry peers (1.5%). Reported Earnings • May 05
First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.009 loss in 1Q 2022) First quarter 2023 results: EPS: US$0.022 (up from US$0.009 loss in 1Q 2022). Revenue: US$11.9m (up 2.7% from 1Q 2022). Net income: US$257.0k (up US$362.0k from 1Q 2022). Profit margin: 2.2% (up from net loss in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Announcement • May 04
Natural Health Trends Corp. Declares a Quarterly Cash Dividend, Payable on May 26, 2023 On May 1, 2023, Natural Health Trends Corp.’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on May 26, 2023 to stockholders of record as of May 16, 2023. Announcement • Feb 15
Natural Health Trends Corp. announced that it has received $0.042592 million in funding On February 14, 2023, Natural Health Trends Corp. closed the transaction. The transaction included participation from four non-accredited investors. Reported Earnings • Feb 09
Full year 2022 earnings released: EPS: US$0.028 (vs US$0.098 in FY 2021) Full year 2022 results: EPS: US$0.028 (down from US$0.098 in FY 2021). Revenue: US$49.1m (down 18% from FY 2021). Net income: US$313.0k (down 71% from FY 2021). Profit margin: 0.6% (down from 1.8% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Feb 09
Natural Health Trends Corp. Declares Quarterly Cash Dividend, Payable on March 3, 2023 Natural Health Trends Corp. Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on March 3, 2023 to stockholders of record as of February 21, 2023. Announcement • Feb 02
Natural Health Trends Corp. to Report Q4, 2022 Results on Feb 08, 2023 Natural Health Trends Corp. announced that they will report Q4, 2022 results at 9:00 AM, US Eastern Standard Time on Feb 08, 2023 Buying Opportunity • Jan 14
Now 21% undervalued Over the last 90 days, the stock is up 11%. The fair value is estimated to be US$5.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has grown by 64%. Upcoming Dividend • Nov 07
Upcoming dividend of US$0.20 per share Eligible shareholders must have bought the stock before 14 November 2022. Payment date: 25 November 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 19%. Within top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.4%). Reported Earnings • Nov 03
Third quarter 2022 earnings released: EPS: US$0.004 (vs US$0.043 in 3Q 2021) Third quarter 2022 results: EPS: US$0.004 (down from US$0.043 in 3Q 2021). Revenue: US$11.7m (down 18% from 3Q 2021). Net income: US$47.0k (down 90% from 3Q 2021). Profit margin: 0.4% (down from 3.3% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$4.01, the stock trades at a trailing P/E ratio of 58.7x. Average trailing P/E is 15x in the Personal Products industry in the US. Total loss to shareholders of 20% over the past three years. Buying Opportunity • Sep 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 28%. The fair value is estimated to be US$5.97, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% over the last 3 years. Earnings per share has declined by 7.7%. Upcoming Dividend • Aug 08
Upcoming dividend of US$0.20 per share Eligible shareholders must have bought the stock before 15 August 2022. Payment date: 26 August 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 14%. Within top quartile of American dividend payers (4.1%). Higher than average of industry peers (1.1%). Reported Earnings • Aug 04
Second quarter 2022 earnings released: EPS: US$0.016 (vs US$0.021 in 2Q 2021) Second quarter 2022 results: EPS: US$0.016 (down from US$0.021 in 2Q 2021). Revenue: US$13.4m (down 17% from 2Q 2021). Net income: US$183.0k (down 20% from 2Q 2021). Profit margin: 1.4% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment deteriorated over the past week After last week's 18% share price decline to US$5.55, the stock trades at a trailing P/E ratio of 76x. Average trailing P/E is 15x in the Personal Products industry in the US. Total loss to shareholders of 6.1% over the past three years. Upcoming Dividend • May 09
Upcoming dividend of US$0.20 per share Eligible shareholders must have bought the stock before 16 May 2022. Payment date: 27 May 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 11%. Within top quartile of American dividend payers (4.0%). Higher than average of industry peers (1.2%). Reported Earnings • May 05
First quarter 2022 earnings released: US$0.009 loss per share (vs US$0.014 profit in 1Q 2021) First quarter 2022 results: US$0.009 loss per share (down from US$0.014 profit in 1Q 2021). Revenue: US$11.5m (down 14% from 1Q 2021). Net loss: US$105.0k (down 169% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Recent Insider Transactions Derivative • Mar 18
President exercised options and sold US$109k worth of stock On the 15th of March, Chris T. Sharng exercised options to acquire 16k shares at no cost and sold these for an average price of US$7.01 per share. This trade did not impact their existing holding. For the year to December 2020, Chris T.'s total compensation was 99% salary and 1% non-salary. Since December 2021, Chris T. has owned 886.65k shares directly. Company insiders have collectively sold US$896k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Feb 11
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: US$0.098 (up from US$0.079 in FY 2020). Revenue: US$60.0m (down 3.3% from FY 2020). Net income: US$1.09m (up 29% from FY 2020). Profit margin: 1.8% (up from 1.4% in FY 2020). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment improved over the past week After last week's 16% share price gain to US$7.42, the stock trades at a trailing P/E ratio of 45.5x. Average trailing P/E is 17x in the Personal Products industry in the US. Total loss to shareholders of 57% over the past three years. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$6.36, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 17x in the Personal Products industry in the US. Total loss to shareholders of 67% over the past three years. Upcoming Dividend • Aug 09
Upcoming dividend of US$0.20 per share Eligible shareholders must have bought the stock before 16 August 2021. Payment date: 27 August 2021. Trailing yield: 11%. Within top quartile of American dividend payers (3.5%). Higher than average of industry peers (0.8%). Reported Earnings • Aug 05
Second quarter 2021 earnings released: EPS US$0.021 (vs US$0.003 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: US$16.2m (down 1.5% from 2Q 2020). Net income: US$229.0k (up US$195.0k from 2Q 2020). Profit margin: 1.4% (up from 0.2% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Executive Departure • May 19
Director has left the company On the 11th of May, George Knute Broady's tenure as Director ended after 12.6 years in the role. We don't have any record of a personal shareholding under George Knute's name. A total of 2 executives have left over the last 12 months. Upcoming Dividend • May 10
Upcoming dividend of US$0.20 per share Eligible shareholders must have bought the stock before 17 May 2021. Payment date: 28 May 2021. Trailing yield: 10%. Within top quartile of American dividend payers (3.4%). Higher than average of industry peers (0.8%). Reported Earnings • May 05
First quarter 2021 earnings released: EPS US$0.014 (vs US$0.055 loss in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: US$13.5m (down 9.9% from 1Q 2020). Net income: US$153.0k (up US$726.0k from 1Q 2020). Profit margin: 1.1% (up from net loss in 1Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 02
Full year 2020 earnings released: EPS US$0.079 (vs US$0.52 loss in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$62.1m (down 20% from FY 2019). Net income: US$843.0k (up US$6.45m from FY 2019). Profit margin: 1.4% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 88% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Feb 15
Upcoming Dividend of US$0.20 Per Share Will be paid on the 5th of March to those who are registered shareholders by the 22nd of February. The trailing yield of 10% is in the top quartile of American dividend payers (3.8%), and it is higher than industry peers (0.8%). Reported Earnings • Feb 12
Full year 2020 earnings released: EPS US$0.079 (vs US$0.52 loss in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$62.1m (down 20% from FY 2019). Net income: US$843.0k (up US$6.45m from FY 2019). Profit margin: 1.4% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 88% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 04
New 90-day high: US$5.97 The company is up 8.0% from its price of US$5.53 on 05 November 2020. The American market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: US$5.23 The company is down 13% from its price of US$6.00 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period. 
